Vitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine Neoplasia
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safest dose of the study drug Vitamin E
Delta-tocotrienol, how often it should be taken, and how well people with pancreatic tumors
tolerate Vitamin E Delta-tocotrienol.
Phase:
Phase 1
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Collaborator:
National Cancer Institute (NCI)
Treatments:
alpha-Tocopherol Tocopherols Tocotrienols Vitamin E Vitamins